Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Uxin (UXIN) EBT (2018 - 2025)

Historic EBT for Uxin (UXIN) over the last 8 years, with Q3 2025 value amounting to -$60.7 billion.

  • Uxin's EBT rose 146.27% to -$60.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$60.7 billion, marking a year-over-year increase of 6938.53%. This contributed to the annual value of -$46.4 million for FY2024, which is N/A changed from last year.
  • Per Uxin's latest filing, its EBT stood at -$60.7 billion for Q3 2025, which was up 146.27% from -$9.4 million recorded in Q2 2025.
  • Uxin's EBT's 5-year high stood at $120.2 billion during Q4 2021, with a 5-year trough of -$266.1 billion in Q3 2021.
  • For the 5-year period, Uxin's EBT averaged around -$32.5 billion, with its median value being -$9.4 million (2025).
  • As far as peak fluctuations go, Uxin's EBT skyrocketed by 44055313.46% in 2021, and later plummeted by 78810123060.39% in 2024.
  • Over the past 5 years, Uxin's EBT (Quarter) stood at $120.2 billion in 2021, then crashed by 100.0% to -$100764.0 in 2022, then rose by 22.52% to -$78070.0 in 2023, then plummeted by 15752.44% to -$12.4 million in 2024, then crashed by 490341.18% to -$60.7 billion in 2025.
  • Its last three reported values are -$60.7 billion in Q3 2025, -$9.4 million for Q2 2025, and -$7.1 million during Q1 2025.